Skip to main content
. Author manuscript; available in PMC: 2017 Jan 5.
Published in final edited form as: Bone Marrow Transplant. 2016 Jul 18;52(1):59–65. doi: 10.1038/bmt.2016.188

Figure 1.

Figure 1

(a) Cumulative incidence of relapse or progression of AML following HCT, (b) Cumulative incidence of TRM for AML not in remission at HCT receiving CloBu4 conditioning.